🔎 Trials Near Me

Home › Sakit ni Alzheimer

Pag-aaral pangklinika para sa Sakit ni Alzheimer na nagre-recruit sa U.S.

243 pag-aaral para sa Sakit ni Alzheimer ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.

Mga lungsod na may pinakamaraming pag-aaral

Ayos sa estado

Mga pag-aaral na kamakailan lamang in-update

Opisyal na teksto ng pag-aaral (English)

PET Imaging in the Baltimore Longitudinal Study of Aging (BLSA)

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 55 hanggang 110 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07099053

Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 89 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT04800588

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 65 hanggang 120 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07721467

Adaptango Performance PRocess for Older Adults Community reHabilitation

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07824128

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Nagre-recruitPhase 2
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06887192

A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD

Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05231785

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

Nagre-recruitPhase 3
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06937229

Make Better Choices 2 for Rural Appalachians

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT04309461

Tennessee Alzheimer's Project

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 60 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT05372172

Testing the Effects of a Text Message Caregiver Support Intervention for Latinos

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06728436

CMN LIFU for Enhanced Amyloid Reduction (CLEART Study)

Nagre-recruit
Edad 65 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07866768

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

Nagre-recruitPhase 3
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07011732

HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 60 hanggang 100 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06930560

A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

Nagre-recruitPhase 2
Edad 55 hanggang 85 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07688213

A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

Nagre-recruitPhase 3
Edad 55 hanggang 80 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07717411

Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease

Nagre-recruitPhase 1/2
Edad 50 hanggang 86 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07651319

Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease

Nagre-recruitPhase 2
Edad 50 hanggang 90 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07781657

Flutemetamol F 18 Injection Formulation Comparison

Nagre-recruitPhase 2
Edad 50 hanggang 110 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07873463

A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07787169

A Study of LY3439539 in Participants With Alzheimer's Disease

Nagre-recruitPhase 1
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07598370

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Nagre-recruitPhase 2
Edad 55 hanggang 85 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07589595

A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease

Nagre-recruitObservasyonal na pag-aaral
Edad 60 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06566170

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

Nagre-recruitPhase 3
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07011745

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Nagre-recruitPhase 2
Edad 55 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06540833

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.